Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

By person

16 insiders · 1 transaction
50.8×

Richard F. Pops holds 50.8 times base salary in stock. $63.61M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard F. Pops last reported holding, valued at $46.17, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
David Joseph Gaffin
EVP, CLO, Alkermes, Inc.
—
$93.96K (1) scheduled
−$93.96K
219,353
0.1308%
$10.13M
+32.2%
Richard F Pops
Director and CEO, Alkermes plc
—
—
—
1,377,740
0.8212%
$63.61M
+16.8%
Blair Curtis Jackson
President & CEO, Alkermes plc
—
—
—
241,308
0.1438%
$11.14M
+52.9%
Iain Michael Brown
SVP, Chief Financial Officer
—
—
—
148,196
0.0883%
$6.84M
+27.4%
Shane Cooke
Director
—
—
—
106,679
0.0636%
$4.93M
+6.8%
Christian Todd Nichols
SVP, Chief Commercial Officer
—
—
—
102,193
0.0609%
$4.72M
+55.0%
Craig C. Hopkinson
EVP R&D, Chief Medical Officer
—
—
—
65,389
0.0390%
$3.02M
−40.4%
Brian P McKeon
Director
—
—
—
38,536
0.0230%
$1.78M
+38.7%
Frank Anders Wilson
Director
—
—
—
35,751
0.0213%
$1.65M
+43.0%
Richard Gaynor
Director
—
—
—
35,751
0.0213%
$1.65M
+43.0%
Cato T Laurencin
Director
—
—
—
33,769
0.0201%
$1.56M
+70.5%
Christopher I Wright
Director
—
—
—
25,680
0.0153%
$1.19M
+78.1%
Nancy Lurker
Director
—
—
—
18,222
0.0109%
$841.31K
—
nancy lynn MD snyderman
Director
—
—
—
15,395
0.0092%
$710.79K
+231.9%
Samuel Joseph Parisi
VP, Finance (Interim PAO)
—
—
—
7,717
0.0046%
$356.29K
0.0%
Joshua Reed
SVP, Chief Financial Officer
—
—
—
5,095
0.0030%
$235.24K
—